Industry Lobbying Spurs Trump Reconsideration of Marijuana’sInternal anchor suggestions: Schedule III classification impact; DEA rescheduling process; Trump fundraiser policy signals; Industry tax relief under 280E For years, cannabis advocates have been chasing the political equivalent
Sheriff Tompkins accused of committing extortion by leveraging licensing ties to demand $50K in stock from a cannabis company preparing for its IPO When federal prosecutors unsealed an indictment on Aug. 8, 2025, against Suffolk
Federal drug policy is shifting as Congress uses funding bills to expand veteran access to cannabis and psychedelics while modernizing VA health care. In Washington, change often arrives not with sweeping declarations but embedded in
Intensified ICE enforcement targeting Hispanic cannabis labor reveals deep legal conflicts, human rights concerns, and economic impacts within America’s growing cannabis industry. As cannabis legalization sweeps across the United States, transforming the industry into a
In an industry defined as much by its volatility as its promise, Ayr Wellness remains a bellwether of the modern cannabis operator’s dilemma. With a footprint that spans multiple states, the company finds itself entrenched
Texas House Bill 46, signed into law by Governor Greg Abbott on June 21, 2025, represents the most substantial transformation of the state’s medical cannabis policy since the creation of the Texas Compassionate Use Program
Harold & Kumar return in a bold reboot that blends classic stoner comedy with fresh cultural relevance for a new generation. The stoner comedy, as a genre, occupies a peculiar cultural sweet spot. Equal parts
Meta’s uneven cannabis content moderation stifles legal industry voices while allowing sensational sex and violence to thrive online. Meta’s platforms (Facebook, Instagram and Threads) have long promised openness, yet in practice they enforce a strict
Oregon’s psilocybin therapy access lawsuit challenges restrictions on home treatment, raising national questions about disability rights, medical equity, and drug policy. Oregon’s bold experiment with psilocybin therapy – legalized in 2020 by Measure 109 –
Minnesota ends harsh penalties for bong water possession, marking a pivotal shift toward more rational and equitable drug policy. For years, Minnesota’s so-called “bong water law” served as a punchline to outsiders and a policy
Ongoing disputes over community impact fees in Massachusetts highlight regulatory gaps, threatening equity goals and straining cannabis industry sustainability. The High Cost of Compliance in a Low-Margin Market Massachusetts cannabis operators are facing a slow-burning
Just Say Know? The DEA Meme Campaign and the Politics of Cannabis Prevention. During National Prevention Week 2025, the Drug Enforcement Administration launched a cannabis prevention campaign that’s difficult to take seriously and harder still